List of SBIR/STTR awards granted to Epivax, Inc.

List of SBIR/STTR awards granted to Epivax, Inc.

List of SBIR/STTR awards granted to Exelus, Inc.

List of SBIR/STTR awards granted to AVENDA SYSTEMS

List of SBIR/STTR awards granted to Algomedix

List of Techstars Class 286 - Music 2022 T1 companies

List of Goldman Sachs patents

where

SBIR/STTR Award Recipient

is

‌

Epivax, Inc.

	Name	Description	SBIR/STTR Award Recipient	Government Agency	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
	‌ EPIVAX, INC. SBIR Phase I Award, May 2018	A SBIR Phase I contract was awarded to Epivax, Inc. in May, 2018 for $324,980.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Epivax, Inc.		National Institutes of Health	SBIR	1R43TR002441-01	Phase I	324,980	May 9, 2018	sbir.gov/node/1574827
	‌ EPIVAX, INC. SBIR Phase I Award, September 2017	A SBIR Phase I contract was awarded to Epivax, Inc. in September, 2017 for $316,862.0 USD from the U.S. Department of Health & Human Services.	‌ Epivax, Inc.			SBIR	1R43DK115365-01	Phase I	316,862	September 1, 2017	sbir.gov/node/1326253
	‌ EPIVAX, INC. SBIR Phase I Award, July 2016	A SBIR Phase I contract was awarded to Epivax, Inc. in July, 2016 for $590,546.0 USD from the U.S. Department of Health & Human Services.	‌ Epivax, Inc.			SBIR	1R43AI118189-01A1	Phase I	590,546	July 1, 2016	sbir.gov/node/1163257
	‌ EPIVAX, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Epivax, Inc. for $609,910.0 USD from the U.S. Department of Health & Human Services.	‌ Epivax, Inc.			SBIR	1R43AI065036-01	Phase I	609,910		sbir.gov/content/genome-derived-epitope-driven-h-pylori-vaccine-0
	‌ EPIVAX, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Epivax, Inc. for $831,922.0 USD from the U.S. Department of Health & Human Services.	‌ Epivax, Inc.			SBIR	1R43AI058326-01A1	Phase I	831,922		sbir.gov/content/genome-derived-epitope-driven-tularemia-vaccine-0
	‌ EPIVAX, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Epivax, Inc. for $263,867.0 USD from the U.S. Department of Health & Human Services.	‌ Epivax, Inc.			SBIR	1R43HL088834-01	Phase I	263,867		sbir.gov/content/epitope-driven-deimmunization-factor-viii-0
	‌ EPIVAX, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Epivax, Inc. for $299,908.0 USD from the U.S. Department of Health & Human Services.	‌ Epivax, Inc.			SBIR	1R43AI075830-01	Phase I	299,908		sbir.gov/content/optimization-multivalent-tuberculosis-vaccine-0
	‌ EPIVAX, INC. SBIR Phase II Award,	A SBIR Phase II contract was awarded to Epivax, Inc. for $1,474,236.0 USD from the U.S. Department of Health & Human Services.	‌ Epivax, Inc.			SBIR	2R44DK081261-03A1	Phase II	1,474,236		sbir.gov/node/389115
	‌ EPIVAX, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Epivax, Inc. for $600,000.0 USD from the U.S. Department of Health & Human Services.	‌ Epivax, Inc.			SBIR	1R43AI102454-01	Phase I	600,000		sbir.gov/node/399832
	‌ EPIVAX, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Epivax, Inc. for $1,027,410.0 USD from the U.S. Department of Health & Human Services.	‌ Epivax, Inc.			SBIR	1R43AI058376-01A1	Phase I	1,027,410		sbir.gov/content/novel-smallpox-vaccine-derived-vvvar-immunome-0
	‌ EPIVAX, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Epivax, Inc. for $599,999.0 USD from the U.S. Department of Health & Human Services.	‌ Epivax, Inc.			SBIR	1R43DK081261-01	Phase I	599,999		sbir.gov/content/t1d-tolerance-induction-natural-treg-epitopes-0
	‌ EPIVAX, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Epivax, Inc. for $757,712.0 USD from the U.S. Department of Health & Human Services.	‌ Epivax, Inc.			SBIR	1R43HL114308-01	Phase I	757,712		sbir.gov/node/400854
	‌ EPIVAX, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Epivax, Inc. for $247,768.0 USD from the U.S. Department of Health & Human Services.	‌ Epivax, Inc.			SBIR		Phase I	247,768		sbir.gov/content/epitope-driven-hpv-vaccine-targeting-dentritic-cells-0
	‌ EPIVAX, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Epivax, Inc. for $105,609.0 USD from the U.S. Department of Health & Human Services.	‌ Epivax, Inc.			SBIR		Phase I	105,609		sbir.gov/content/diagnostic-reagents-emerging-infectious-diseases-0
	‌ EPIVAX, INC. SBIR Phase I Award, August 2023	A SBIR Phase I contract was awarded to Epivax, Inc. in August, 2023 for $299,917.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Epivax, Inc.		National Institutes of Health	SBIR	1R43AI174486-01	Phase I	299,917	August 1, 2023	sbir.gov/node/2507473

15 results

0 selected

15 results

0 selected